XRTX Xyratex Ltd.
-
Xyratex Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
Xyratex (XRTX) reported a loss of $1.05 per share on revenue of $0.00 million for the . .
XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($1.05)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—